CVS Group plc (CVSG.L) – What Are Investment Firms Saying About This Stock?

Shares of CVS Group plc (LON:CVSG) have been given a consensus rating of “Moderate Buy” by the six brokerages that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is GBX 1,666.67.

CVSG has been the subject of several analyst reports. Berenberg Bank restated a “buy” rating and issued a GBX 2,000 target price on shares of CVS Group in a research report on Thursday, September 24th. Jefferies Financial Group restated a “hold” rating and set a GBX 1,400 price objective on shares of CVS Group in a research report on Friday, September 25th. Shore Capital Group restated a “hold” rating and set a GBX 1,400 price objective on shares of CVS Group in a research report on Thursday, September 24th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,700 target price on shares of CVS Group in a report on Monday, July 27th.

CVS Group Stock Up 1.4%

LON CVSG opened at GBX 1,317 on Monday. The company has a current ratio of 1.18, a quick ratio of 0.90 and a debt-to-equity ratio of 110.41. The stock’s 50 day moving average is GBX 1,268.16 and its two-hundred day moving average is GBX 1,234.71. CVS Group has a 1-year low of GBX 1,062 and a 1-year high of GBX 1,432. The company has a market capitalization of £888.46 million, a price-to-earnings ratio of 54.20, a PEG ratio of 1.77 and a beta of 1.09.

CVS Group (LON:CVSG) last announced its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 earnings per share for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. Equities analysts forecast that CVS Group will post 93.94 earnings per share for the current fiscal year.

Insider Activity

In other CVS Group news, insider Joanne Shaw bought 1,592 shares of the business’s stock in a transaction on Monday, August 10th. The stock was purchased at an average price of GBX 1,287 per share, for a total transaction of £20,489.04. Also, insider Robin Alfonso acquired 768 shares of CVS Group stock in a transaction that occurred on Thursday, August 6th. The shares were purchased at an average cost of GBX 1,294 per share, with a total value of £9,937.92. Over the last 90 days, insiders have purchased 3,860 shares of company stock worth $4,956,696. Company insiders own 1.48% of the company’s stock.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.